Showing results (21-30 of 4,635) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|August 19, 2010
Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cellsBozhena O Vynnytska, Oksana M Mayevska, Yuliya V Kurlishchuk, et al.
Anti-Cancer Drugs|August 21, 2010
3,3'-Diindolylmethane negatively regulates Cdc25A and induces a G2/M arrest by modulation of microRNA 21 in human breast cancer cellsYucui Jin, Xianghong Zou, Xiaoling Feng
Anti-Cancer Drugs|July 31, 2010
Successful dexrazoxane treatment of a potentially severe extravasation of concentrated doxorubicinDavid Conde-Estévez, Silvia Saumell, Antonio Salar, et al.
Anti-Cancer Drugs|July 17, 2010
A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinomaJen-Shi Chen, Yee Chao, Yung-Jue Bang, et al.
Anti-Cancer Drugs|July 13, 2010
Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytomaJavier Martinez-Trufero, Jorge Alfaro, Francesc Felipo, et al.
Anti-Cancer Drugs|June 19, 2010
Effect of free fatty acids and lysolipids on cellular uptake of doxorubicin in human breast cancer cell linesNicolaj Rasmussen, Jonas H Andersen, Henrik Jespersen, et al.
Anti-Cancer Drugs|September 14, 2010
Long-term survival of induction chemotherapy plus surgery and postoperative radiotherapy in patients with stage IV hypopharyngeal cancerLei Yang, Wen-Kuan Chen, Zhu-Ming Guo, et al.
Anti-Cancer Drugs|June 24, 2010
XPC gene intron 11 C/A polymorphism is a predictive biomarker for the sensitivity to NP chemotherapy in patients with non-small cell lung cancerLi-Bo Zhu, Qian Xu, Cheng-Yu Hong, et al.
Anti-Cancer Drugs|June 24, 2010
Combined phase I/II study of imexon (AOP99.0001) for treatment of relapsed or refractory multiple myelomaThomas M Moehler, Reinhard Feneberg, Anthony Dick Ho, et al.
Anti-Cancer Drugs|August 4, 2010
Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?Sandra Geiger, Marcus Schlemmer, Volker Heinemann, et al.
Pageof 464